CANCER stem cells, which fuel the growth of fatal tumours, can be knocked out by a one-two combination of antibiotics and Vitamin C in a new experimental strategy, published by researchers at the University of Salford, UK.
The antibiotic, Doxycycline, followed by doses of ascorbic acid (Vitamin C), were surprisingly effective in killing the cancer stem cells under laboratory conditions, according to the research published in the journal Oncotarget.
In boxing terms, this would be the equivalent of two blows delivered in rapid succession; a left-hand jab, followed by a right cross.
The researchers say their method offers a new explanation for how to prevent cancer cells from becoming treatment-resistant and how combinations therapies can be developed to overcome drug resistance.
Starve cancer cells
Professor Michael Lisanti, who designed the study, explained: “We now know that a proportion of cancer cells escape chemotherapy and develop drug resistance; we established this new strategy to find out how they do it.
“We suspected the answer lay in the fact that certain cancer cells – which we call metabolically flexible – are able to switch their fuel source. Thus, when the drug treatment reduces the availability of a particular nutrient, the flexible cancer cells can feed themselves with an alternative energy source.”
This new combination approach prevents cancer cells from changing their diet (metabolically inflexible), and effectively starves them, by preventing them from using any other available types of bio-fuels.
The team at the University of Salford’s Biomedical Research Centre, added Doxycycline in ever increasing doses over a three-month period, to induce metabolic inflexibility. The result was to leave the cancer cells alive, but severely attenuated and depleted, so that they would be much more susceptible to starvation, by a second metabolic “punch”.
First, the researchers inhibited the tumour cell mitochondria, by restricting the cancer cells only to glucose as a fuel source; then, they took away their glucose, effectively starving the cancer cells to death.
“In this scenario, Vitamin C behaves as an inhibitor of glycolysis, which fuels energy production in mitochondria, the “powerhouse” of the cell, explained co-author Dr Federica Sotgia.
The Salford team recently showed Vitamin C to be up to ten times more effective at stopping cancer cell growth than pharmaceuticals such as 2-DG, but they say that when Vitamin C is combined with an antibiotic, it is up to ten times more effective, making it nearly 100 times more effective than 2-DG.
As Doxycycline and Vitamin C are both relatively non-toxic, this could dramatically reduce the possible side-effects of anti-cancer therapy.
The Salford team also identified eight other drugs that could be used as a “second-punch” after the antibiotic regime, including berberine (a natural product) – and a number of cheap non-toxic FDA approved drugs.
Professor Lisanti added: “This is further evidence that Vitamin C and other non-toxic compounds may have a role to play in the fight against cancer.
“Our results indicate it is a promising agent for clinical trials, and a as an add-on to more conventional therapies, to prevent tumour recurrence, further disease progression and metastasis.”
The Latest on: Cancer stem cells
- A marker-independent lineage-tracing system to quantify clonal dynamics and stem cell functionality in cancer tissueon August 16, 2019 at 8:21 am
Lineage tracing is a powerful tool that can be used to uncover cell fates. Here, we describe a novel method for the quantitative analysis of clonal dynamics in grafted cancer tissues. The protocol ...
- Despite failed promises, stem cell advocates again want taxpayers to pony up billionson August 16, 2019 at 8:08 am
Californians voted in 2004 to shell out billions of dollars in taxpayer money to fund cutting-edge stem cell treatments. Proposition 71 could lead to cures for cancer, Alzheimer's and other ...
- Frozen assets: How a startup wants to cryobank your cells to fight cancer in the futureon August 15, 2019 at 3:27 pm
Even then, only roughly two in 10 cancer patients achieve long-lasting responses, and some patients may not have enough healthy T cells to extract. Wait a second, Kirk thought: If women can freeze ...
- Short on cures and cash – California’s stem cell agency to ask voters for billions moreon August 15, 2019 at 5:00 am
Renee C. Byer [email protected] Californians voted in 2004 to shell out billions of dollars in taxpayer money to fund cutting-edge stem cell treatments. Proposition 71 could lead to cures for cancer, ...
- Scientists Turn Breast Cancer Cells Into Fat, Stops Disease From Spreading, Report Sayson August 14, 2019 at 2:11 am
Scientists Successfully Turn Breast Cancer Cells Into Fat to Stop Them From Spreading' https://t.co/daL2uUjn22 Paper: https://t.co/UA2dPcaKiG pic.twitter.com/3FqA7RxEAW — Stem Cell Foundation ...
- Cancer Stem Cell Market: Industry Growth, Competitive Analysis, Future Prospects and Forecast 2023on August 13, 2019 at 2:15 pm
Aug 13, 2019 (AmericaNewsHour) -- Market Study Report LLC added report on Cancer Stem Cell Market that evaluates industry growth trends through historical data and estimates future prospects based on ...
- BMP-4 enhances epithelial mesenchymal transition and cancer stem cell properties of breast cancer cells via Notch signalingon August 13, 2019 at 2:19 am
Bone morphogenetic protein (BMP) signaling and Notch signaling play important roles in tumorigenesis in various organs and tissues, including the breast. BMP-4 enhanced epithelial mesenchymal ...
- Cancer Stem Cells Market Size, Share, Analysis, Opportunities and Forecast 2019 – 2025on August 12, 2019 at 11:14 pm
Cancer Stem Cells Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025- Increasing cases of cancer-related morbidity across the world will fuel the demand for cancer ...
- Propanc Biopharma Publishes Key Data in Peer Reviewed Journal Confirming Anti-Cancer Stem Cell Effects of Proenzymeson August 12, 2019 at 5:14 am
Propanc Biopharma, Inc. (OTC: PPCBD) ("Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that ...
- Treatment with both targeted cancer therapy and MS drug halts glioblastoma stem cellson August 8, 2019 at 9:55 pm
Glioblastoma is an aggressive form of brain cancer that infiltrates surrounding brain tissue, making it extremely difficult to treat with surgery. Even when chemotherapy and radiation successfully ...
via Google News and Bing News